CTOs on the Move


 
MSI Methylation Sciences Inc. (“MSI”) is a clinical-stage pharmaceutical company focused on developing new products based on molecules which have clinical proof of concept but which have yet to be exploited in the major pharmaceutical markets. MSI`s focus is in the CNS space where clinical proof of concept is key to reducing the drug development risk. Our lead product candidate, Strada™, is based upon Ademetionine, a naturally occurring molecule produced throughout the body, where it plays a vital role in the one-carbon cycle. Our disease indication is Major Depressive Disorder (MDD).
  • Number of Employees: 0-25
  • Annual Revenue: $0-1 Million

Executives

Name Title Contact Details

Funding

MSI raised $30M on 10/07/2016

Similar Companies

BridgeHealth

BridgeHealth connects people with the nation`s best surgical care for a better experience, better outcomes, and better value. We offer a value-based approach to surgical care for self-insured plan sponsors and their members, saving them an average of 30% to 50% on procedures compared with PPO rates. BridgeHealth`s nationwide Centers of Excellence focus on quality outcomes and provide pre-negotiated bundled case rates for a broad scope of surgical procedures, including musculoskeletal, neurological, general surgery, cardiac, bariatric, and women`s health. BridgeHealth contracts with hospital providers who rank in the top quartile for their clinical specialty, based on outcomes and other objective measures, as well as top-rated ambulatory surgery centers. Plan members gain access to some of the best providers in the country, with little to no out-of-pocket expense. They receive concierge-level service, with a personal care coordinator to assist them every step of the way. They also have access to unbiased decision support tools to help them with second opinions, alternative treatments, and provider selection. Plan sponsors recognize significant cost savings, increased engagement, and increased productivity, along with recruitment and retention advantages, by offering a benefit that improves outcomes and reduces costs.

RPS ReSearch Pharmaceutical Services

In 1998, RPS began building the foundation for the PRO model in anticipation of evolving clinical strategies within Sponsor companies. By integrating its personnel and systems with those of Sponsor companies, RPS has helped industry leaders achieve significant cost savings, flexible program staffing, and standardized system operations on a global scale.

Community Hospital Corporation

Community Hospital Corporation owns, manages and consults with hospitals through three distinct organizations — CHC Hospitals, CHC Consulting and CHC ContinueCARE, which share a common purpose to guide, support and enhance the mission of community hospitals and healthcare providers.

Talcomp

Talcomp is a Houston, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

OSU Medical Center

The Ohio State University Medical Center (OSUMC) is a multidisciplinary academic medical center located in Columbus, Ohio